www.fdanews.com/articles/69991-teva-receives-tentative-approval-for-generic-topiramate
Teva Receives Tentative Approval for Generic Topiramate
March 18, 2005
Teva Pharmaceutical has received tentative approval from the FDA to market topiramate capsules in 15- and 25-mg strengths.
Topiramate is the generic equivalent of Ortho-McNeil Pharmaceutical's Topamax, and is used to treat migraines and cluster headaches, epilepsy, and weight loss.